What You Should Know:
– GeneDx, a leader in genomic insights, has announced the launch of GeneDx Discover, a groundbreaking data visualization tool designed to revolutionize drug discovery and development.
– The platform provides biopharmaceutical companies with access to de-identified and aggregated genetic data, empowering them to accelerate the development of new therapies.
Addressing the Challenges of Drug Development
The traditional drug development process is lengthy, costly, and often unsuccessful. On average, it takes 12 years and $2.6 billion to bring a new drug to market, with a 90% failure rate. GeneDx Discover aims to address these challenges by leveraging the power of genetic data to improve decision-making and accelerate the development timeline.
Unlocking the Potential of Genetic Data
GeneDx Discover provides biopharmaceutical companies with:
- Access to a vast dataset: Leverages GeneDx’s industry-leading database of over 700,000 clinical exomes and genomes.
- Self-service data exploration: Offers an easy-to-use interface for exploring and analyzing genetic data.
- Deeper understanding of patient populations: Provides insights into disease prevalence, phenotypic information, and variant-level details.
- Enhanced decision-making: Enables data-driven decisions throughout the drug development process.
- Accelerated development timelines: Helps identify promising drug candidates and streamline clinical trials.
GeneDx Discover is the latest addition to GeneDx’s portfolio of solutions aimed at improving health outcomes through genomic insights. The company is committed to collaborating with biopharmaceutical companies to accelerate drug development, expand access to genetic testing, and ultimately improve patient care.
